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days post-stroke) and early patients. Models accounting for patient health utility 
were significantly different (p< 0.05). ConClusions: These findings complement 
the more descriptive summaries of a comprehensive matrix of sources of support 
within regions and localities (Department of Health, 2007), with which people living 
with stroke may interact. Exploring what patients and carers consider important 
in the provision of stroke support services, will ensure that service re-design is 
user-focused to maximum utility.
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objeCtives: Diseases of the cardiovascular system are the main causes of death in 
Germany and other industrial countries. Different therapeutic approaches exist as 
well as several treatment options. How people who have suffered from an acute cor-
onary syndrome, value aspects of their medical treatment is not very well analyzed 
until today. The objective of this empirical investigation was to evaluate patient’s 
preferences regarding different antiplatelet medication options following an acute 
coronary syndrome. Methods: Primary method was a Discrete-Choice-Experiment 
that included 6 patient-relevant attributes. Furthermore an Analytic-Hierarchy 
Process (AHP) was used to test the applicability of the method and to compare the 
results. The Discrete-Choice-Experiment (DCE) was conducted using a fractional 
factorial NGene-design with priors and the statistical data analysis used a random 
effect logit model. AHP was conducted using the eigenvalue method. Results: The 
preference analysis of N= 683 patients showed a clear dominance for the attribute 
“reduction of the risk of death” (DCE coef.: 0.803; AHP coef.: 0.402.). Rank 2 in AHP 
the “reduction of heart attack risk” (DCE coef: 0.464; AHP coef.: 0.272.) and in the 
DCE was “shortness of breath” (DCE coef.: 0.550; AHP coef.: 0.165.). The side effect 
of “bleeding” (DCE coef.: 0.400; AHP coef.: 0.117.) joined accordingly. The “frequency 
of administration” was less important in DCE and AHP (DCE coef: 0.025; AHP coef. 
0,044.). ConClusions: The results of both methods generated an almost equal 
ranking of the included features. The highest value for patients within a treatment 
decision was the mortality reduction. The consideration of patient preferences in 
therapeutic decisions implies stronger patient focus and can at the same time be 
used for the development of effective therapies after acute coronary syndrome. 
The preference data generated can be used for health care decision makers and 
stakeholders to represent the patient’s benefit at the same time.
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objeCtives: To assess the performance of the EQ-5D-5L Japanese version com-
pared with the EQ-5D-3L in clinical setting targeted at patients with stroke in 
Japan. Methods: The stroke patients were recruited from six rehabilitation hos-
pitals in Japan. The proxy of the patients completed a questionnaire including the 
two versions of the EQ-5D. We tested the inconsistency, the redistribution proper-
ties, and the ceiling effect. Results: A total 533 patients were recruited: 61% male, 
15-99 (mean= 67) years old. Diagnoses of patients were infarction (54.6%), hemor-
rhage (35.5%), and other (9.9%). The proportion of inconsistent responses (i.e., 3L 
responses that were at least two levels away from the 5L responses) was 3.6%. In 
particular the proportion in MOBILTY was 14.6%. Regarding redistribution, 52-61% 
of the patients answering level 2 with the 3L version redistributed their responses 
to levels 2 or 4 with the 5L version. A relative 3% reduction of the ceiling effect was 
found. ConClusions: Our findings suggest that the EQ-5D-5L Japanese version 
performs better in at least some properties analyzed. Further study is necessary to 
clarify other psychometric properties.
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objeCtives: Existing evidences indicate that single-pill antihypertensive combina-
tions (SPC) have greater rates of adherence and more effective lowering of blood 
pressure than free-drug combinations (FC). SPC therapy has been used in Korea for 
the purpose of achieving optimal blood pressure control. However it is questioned 
whether such existing positive evidence toward SPC from western countries can 
be found in the Korean population. Methods: This study compared compliance, 
persistence and blood pressure change of SPC versus FC using the medical charts of 
1,940 patients from 17 Korean general hospitals (GH1-17). The hypertensive patients 
with SPC or FC prescription, more than 40 years old, no history of hospitalization, 
visited GH1-17 from January 1, 2010 to December 31, 2011 were included. Compliance 
was compared using the Medication Progression Ratio (MPR), calculated as the ratio 
between the days medication was taken and days in a time interval. Persistence was 
measured as the number of days from the index date to the therapy discontinuation 
date. The blood pressure (BP) change was calculated as the difference between the first 
and the last visit. Results: Overall compliance measured by MPR was 0.71 for the 
SPC group and 0.69 for the FC group, with the difference being statistically significant. 
an extremely low quality of life. These findings should be considered in future 
planning of interventions in stroke patients.
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objeCtives: To determine the feasibility of using the Experience Sampling Method 
(ESM) to obtain accounts of the momentary experience of Health Related Quality 
of Life (HRQOL) and compare these to retrospective global measures of HRQOL and 
utilities derived from choice under uncertainty. Methods: An experience-sampling 
study of 139 participants from three different patient groups and a control sample 
examined the momentary experience of HRQOL (mom-HRQOL). Global retrospec-
tive HRQOL measures were also administered. Feasibility of was determined by 
assessing willingness to participate in the study and by analysing the percentage 
of drop-outs and the number of completed beep questionnaires. Bivariate correla-
tions between mom-HRQOL and momentary positive affect (PA), negative affect (NA) 
and physical symptoms (PS) for each participant were determined. Furthermore, 
correlations between mom-HRQOL, PA, NA and PS on the one hand and retrospec-
tive global health (EQ-VAS), the EQ-5D utility, the SF-6D utility and the TTO on the 
other hand were determined. Results: The overall participation rate was low but 
there were no drop-outs and the number of completed beeps was comparable to 
other studies. For most participants, the correlation between mom-HRQOL and 
momentary PA, NA and PS was in the expected direction. Correlations between 
ESM data on HRQOL, PA, NA and PS and retrospective measures were moderate to 
high, with the exception of the TTO. ConClusions: Overall, this study extends our 
knowledge of the similarities and differences between ESM data on HRQOL, feelings 
and symptoms and retrospective measures of HRQOL, which may aid future health 
care research and decision making.
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objeCtives: EUprimecare is a European Union project aimed at analyzing the costs 
and quality of the different models of primary care (PC) in Europe. The aim of this 
paper is to analyze the management of patients with hypertension in PC services 
in Spain compared to other European countries, the satisfaction of these patients 
with PC services and their self-perceived health status. Methods: Cross-sectional 
study. We conducted a population survey by telephone among PC users in each of 
the consortium countries (Germany, Spain, Estonia, Finland, Hungary, Italy and 
Lithuania). The questionnaire included information on sociodemographic charac-
teristics, health status, satisfaction, utilization of PC services, and frequency of 
some interventions carried out by PC professionals. The survey was conducted to 
431-432 PC users in each country (Ntotal = 3020). We use satisfaction, health status 
and sociodemographic variables to consider the situation of patients with hyperten-
sion in PC. Results: The percentage of users of primary care services who reported 
having hypertension in Spain was 21.6% (N = 93), lower than the overall average 
(34.9%). 97% of patients resident in Spain were diagnosed by their primary care 
physicians versus 82.6% of the European average. The 91.4% of patients in Spain 
claimed to be in treatment to hypertension (EU average= 92.3%) and in 92.9% of 
cases the treatment was prescribed by their PC doctors (EU average= 84.5%). Only 
7.5% of patients claimed that their health was poor or very poor, the lowest propor-
tion of all countries evaluated. ConClusions: The patient with hypertension in 
Spain is diagnosed and managed by PC professionals more frequently than in other 
European countries. The self-perception of these patients in Spain is good and they 
were satisfied with the services of AP. The overall satisfaction of the patients with 
AP services was high but not significantly different from other countries.
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objeCtives: To investigate patient and family carer preferences for stroke support 
services. Methods: Discrete choice experiment (DCE) using a fractional factorial 
design, folded into nine binary choices, containing four attributes: format of service 
(group, individual); service provider (hospital stroke team, primary care, voluntary 
sector); provision of additional social and leisure activities (provided, not provided); 
and time to plan and make the journey (1,2,4 hours). Attributes and levels were 
defined by a review of policy documentation and two workshops with patients and 
family carers (n= 8). Patients (six months post-stroke) and their family carers were 
recruited from four stroke-services in Wales, to complete a paper questionnaire 
including the DCE and validated instruments to facilitate pre-specified sub-group 
analyses. Data were analysed in STATA using a random effects logit model. Marginal 
rate of substitution (MRS) used journey time as the value attribute. Results: A total 
of 144/474 (30%) eligible patients requested the questionnaire, 80 (56%) completed 
(mean age 70.8 years (sd 11.1). A total of 34/74 family carers who requested the 
questionnaire completed. All four attributes were significant for patients (p< 0.05), 
only format of service and journey for carers. Patients preferred support services on 
an individual basis (p= 0.00, MRS= 128.61 minutes), with additional social and leisure 
activities (p= 0.00, MRS= 64.07 minutes). Family carers were willing to trade more 
journey time for services provided on an individual basis (p= 0.00, MRS= 273.73 min-
utes). Sub-group analysis showed significant differences between established (> 315 
